Kiran Mazumdar-Shaw, Founder and Executive Chairperson of Biocon, is one of India’s most well-known entrepreneurs. She has managed to do things with a lot of common sense, a lot of determination, and ...

After a successful FY20 which saw new global partnerships and the launch of vital products, Biocon is ready to expand its drug portfolio and establish a new facility in Bengaluru, its founder & CMD ...

BANGALORE, Aug 23 (Reuters) - India's top listed biotechnology firm Biocon Ltd expects revenue growth of 15 percent over the next two years each, while seeking partnerships with global drugmakers for ...

Despite facing pricing pressures that squeezed Biocon's operating margins in the first quarter of 2024-25, Group CEO Peter Bains remains confident about the company's growth prospects. In an interview ...

New Delhi/Mumbai: Biopharmaceutical firm Biocon Ltd will “remain focussed” on reducing its debt taken on to buy the $3.3 billion generics portfolio of American drugmaker Viatris, a top executive said.

By Rishika Sadam Feb 16 (Reuters) - Biocon is aiming for high-double-digit percentage revenue growth as the Indian ...